Sean Christian Schuett Rivrud: Research on Personalizing Thromboprophylaxis Published in JTH and RPTH
Sean Christian Schuett Rivrud, MD/PhD Candidate at the University Medical Center Groningen’s ICU and Department of Hematology, and Medical Student at the University of Groningen, shared a post on LinkedIn:
”This summer I had the opportunity to present the first two chapters of my PhD on personalizing thromboprophylaxis in high-risk patients at the annual conference of the International Society on Thrombosis and Haemostasis (ISTH).
Now I’m very excited that both chapters are now available online in the Journal of Thrombosis and Haemostasis (JTH) and Research and Practice in Thrombosis and Haemostasis.
A big thank you to my incredible collaborators and mentors who made this possible!
Check them out here:
High-dose postpartum thromboprophylaxis in women at high risk of pregnancy-related venous thromboembolism. Read the full article here.
Predicting the risk of venous thromboembolism in critically ill patients (PROVE-IT).Read the full article here.”
Title 1: High-dose postpartum thromboprophylaxis in women at high risk of pregnancy-related venous thromboembolism: a single-center prospective cohort study
Title 2: Predicting the risk of venous thromboembolism in critically ill patients (PROVE-IT): a model development and validation study
Authors: Sean C.S. Rivrud, Èmese R.H. Heijkoop, Marloes A.G. Holswilder–Olde Scholtenhuis, Karina Meijer
Stay updated on all science in the field of hematology with Hemostasis Today.
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis